PURPOSE: Secondary bacterial infections are a common complication of influenza. Innate immune host defenses appear to be impaired following influenza, leading to susceptibility to subsequent bacterial infections. Alternatively activated macrophages (AAM) in the lungs may play a critical role in eliciting the hypersusceptibility to secondary bacterial pneumonia. METHODS: C57BL6 mice were challenged with sublethal doses of the mouse-adapted A/PR/8/34 (PR8) influenza virus or saline and allowed to recover. At complete recovery (day 14), mice were re-challenged with sublethal doses of Streptococcus pneumoniae serotype 3 (Sp3). RESULTS: PR8-recovered mice developed a rapidly fatal pulmonary infection to a 100-fold sublethal pneumococcal challenge, whereas PR8-naive mice demonstrated no mortality or illness. The cytokines which induce AAM (IL-4 and IL-13) and the expression of genes associated with AAM (Arginase-1, FIZZ1, and YM1) were elevated after PR8 infection. Flow cytometry suggests that alveolar macrophages demonstrate the AAM-phenotype, as indicated by MGL-1 and MHCII expression, in response to PR8 infection. Recovery from PR8 was associated with blunted cytokine responses to TLR ligands. CONCLUSIONS: The mechanisms of immune regulation during recovery from influenza are being elucidated. We provide evidence that pulmonary AAM are induced during influenza infection and may contribute to the elicitation of hypersusceptibility to a secondary bacterial infection.
PURPOSE: Secondary bacterial infections are a common complication of influenza. Innate immune host defenses appear to be impaired following influenza, leading to susceptibility to subsequent bacterial infections. Alternatively activated macrophages (AAM) in the lungs may play a critical role in eliciting the hypersusceptibility to secondary bacterial pneumonia. METHODS: C57BL6 mice were challenged with sublethal doses of the mouse-adapted A/PR/8/34 (PR8) influenza virus or saline and allowed to recover. At complete recovery (day 14), mice were re-challenged with sublethal doses of Streptococcus pneumoniae serotype 3 (Sp3). RESULTS: PR8-recovered mice developed a rapidly fatal pulmonary infection to a 100-fold sublethal pneumococcal challenge, whereas PR8-naive mice demonstrated no mortality or illness. The cytokines which induce AAM (IL-4 and IL-13) and the expression of genes associated with AAM (Arginase-1, FIZZ1, and YM1) were elevated after PR8 infection. Flow cytometry suggests that alveolar macrophages demonstrate the AAM-phenotype, as indicated by MGL-1 and MHCII expression, in response to PR8 infection. Recovery from PR8 was associated with blunted cytokine responses to TLR ligands. CONCLUSIONS: The mechanisms of immune regulation during recovery from influenza are being elucidated. We provide evidence that pulmonary AAM are induced during influenza infection and may contribute to the elicitation of hypersusceptibility to a secondary bacterial infection.
Authors: Geert Raes; Lea Brys; Bhola K Dahal; Jef Brandt; Johan Grooten; Frank Brombacher; Guido Vanham; Wim Noël; Pieter Bogaert; Tom Boonefaes; Anne Kindt; Rafaël Van den Bergh; Pieter J M Leenen; Patrick De Baetselier; Gholamreza Hassanzadeh Ghassabeh Journal: J Leukoc Biol Date: 2004-12-09 Impact factor: 4.962
Authors: Koenraad F van der Sluijs; Leontine J R van Elden; Monique Nijhuis; Rob Schuurman; Jennie M Pater; Sandrine Florquin; Michel Goldman; Henk M Jansen; René Lutter; Tom van der Poll Journal: J Immunol Date: 2004-06-15 Impact factor: 5.422
Authors: P'ng Loke; Meera G Nair; John Parkinson; David Guiliano; Mark Blaxter; Judith E Allen Journal: BMC Immunol Date: 2002-07-04 Impact factor: 3.615
Authors: Jessica M Breslow-Deckman; Cynthia M Mattingly; Susan E Birket; Samantha N Hoskins; Tam N Ho; Beth A Garvy; David J Feola Journal: J Immunol Date: 2013-07-05 Impact factor: 5.422
Authors: Joshua M Klonoski; Trevor Watson; Thomas E Bickett; Joshua M Svendsen; Tonia J Gau; Alexandra Britt; Jeff T Nelson; Evelyn H Schlenker; Michael S Chaussee; Agnieszka Rynda-Apple; Victor C Huber Journal: Viral Immunol Date: 2018-06-05 Impact factor: 2.257
Authors: Achsah D Keegan; Kari Ann Shirey; Dayanand Bagdure; Jorge Blanco; Rose M Viscardi; Stefanie N Vogel Journal: Pathog Dis Date: 2016-05-12 Impact factor: 3.166
Authors: Chiguang Feng; Lei Zhang; Chinh Nguyen; Stefanie N Vogel; Simeon E Goldblum; William C Blackwelder; Alan S Cross Journal: J Immunol Date: 2013-09-25 Impact factor: 5.422